XML 130 R116.htm IDEA: XBRL DOCUMENT v3.20.4
SEGMENT INFORMATION Segment Assets (Details) - USD ($)
$ in Millions
 12 Months Ended
Oct. 31, 2020
Oct. 31, 2019
Oct. 31, 2018
Segment Reporting Information [Line Items]      
Segment Reporting Reconciliation Item Assets $ 7,033 $ 7,153  
Cash and cash equivalents 1,441 1,382  
Prepaid expenses 106 94  
Investments 158 102  
Long term and other receivables 114 100  
Deferred Tax Assets, Net of Valuation Allowance 424 402  
Right-of-use asset 175 0  
Other 220 211  
Total assets 9,627 9,452  
Capital expenditures 119 155 $ 177
Other Assets      
Segment Reporting Information [Line Items]      
Right-of-use asset 175    
Other Noncurrent Assets [Member]      
Segment Reporting Information [Line Items]      
Deferred Tax Assets, Net of Valuation Allowance 380 410  
Life Sciences and Applied Markets      
Segment Reporting Information [Line Items]      
Total assets 3,143 3,202  
Capital expenditures 44 59  
Diagnostics and Genomics      
Segment Reporting Information [Line Items]      
Total assets 2,515 2,620  
Capital expenditures 34 48  
Agilent CrossLab      
Segment Reporting Information [Line Items]      
Total assets 1,375 1,331  
Capital expenditures 41 48  
Segment Total      
Segment Reporting Information [Line Items]      
Total assets 7,033 7,153  
Capital expenditures $ 119 $ 155